Cite
Mello-Grand M, Bruno A, Sacchetto L, et al. Two Novel Ceramide-Like Molecules and miR-5100 Levels as Biomarkers Improve Prediction of Prostate Cancer in Gray-Zone PSA. Front Oncol. 2021;11:769158doi: 10.3389/fonc.2021.769158.
Mello-Grand, M., Bruno, A., Sacchetto, L., Cristoni, S., Gregnanin, I., Dematteis, A., Zitella, A., Gontero, P., Peraldo-Neia, C., Ricotta, R., Noonan, D. M., Albini, A., & Chiorino, G. (2021). Two Novel Ceramide-Like Molecules and miR-5100 Levels as Biomarkers Improve Prediction of Prostate Cancer in Gray-Zone PSA. Frontiers in oncology, 11769158. https://doi.org/10.3389/fonc.2021.769158
Mello-Grand, Maurizia, et al. "Two Novel Ceramide-Like Molecules and miR-5100 Levels as Biomarkers Improve Prediction of Prostate Cancer in Gray-Zone PSA." Frontiers in oncology vol. 11 (2021): 769158. doi: https://doi.org/10.3389/fonc.2021.769158
Mello-Grand M, Bruno A, Sacchetto L, Cristoni S, Gregnanin I, Dematteis A, Zitella A, Gontero P, Peraldo-Neia C, Ricotta R, Noonan DM, Albini A, Chiorino G. Two Novel Ceramide-Like Molecules and miR-5100 Levels as Biomarkers Improve Prediction of Prostate Cancer in Gray-Zone PSA. Front Oncol. 2021 Nov 19;11:769158. doi: 10.3389/fonc.2021.769158. eCollection 2021. PMID: 34868998; PMCID: PMC8640468.
Copy
Download .nbib